机构:[1]Department of Biotechnology, Noida Institute of Engineering and Technology (NIET), Greater Noida, India[2]Institute of ClinicalMedicine, University of Eastern Finland, Kuopio, Finland[3]Department of Biotechnology, School of Engineering & Technology(SET), Sharda University, Greater Noida, India[4]Department of Applied Physics, Aalto University, Espoo, Finland[5]West ChinaSchool of Nursing / Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West ChinaHospital, Sichuan University, Chengdu, 610041, Sichuan, China[6]King Fahd Medical Research Center, King Abdulaziz University,P.O. Box 80216, Jeddah 21589, Saudi Arabia[7]Enzymoics, 7 Peterlee Place, Hebersham, NSW 2770 Novel Global Community EducationalFoundation, Australia
第一作者机构:[1]Department of Biotechnology, Noida Institute of Engineering and Technology (NIET), Greater Noida, India
通讯作者:
通讯机构:[3]Department of Biotechnology, School of Engineering & Technology(SET), Sharda University, Greater Noida, India[*1]Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Plot No.32-34, Knowledge Park III, Greater Noida, Uttar Pradesh-201310, India
推荐引用方式(GB/T 7714):
Satyam Rohit,Bhardwaj Tulika,Goel Sachin,et al.miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis.[J].Current pharmaceutical design.2021,27(13):1628-1641.doi:10.2174/1381612826999201001200529.
APA:
Satyam Rohit,Bhardwaj Tulika,Goel Sachin,Jha Niraj Kumar,Jha Saurabh Kumar...&Kesari Kavindra Kumar.(2021).miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis..Current pharmaceutical design,27,(13)
MLA:
Satyam Rohit,et al."miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis.".Current pharmaceutical design 27..13(2021):1628-1641